Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trialsByNadia K. Waheed, MD, MPH,Hattie Hayes,Martin David Harp,Sydney M CragoPublished: October 9th 2025 | Updated: October 16th 2025Ultra-high-resolution OCT advances retinal imaging, enabling detailed visualization of disease progression and potential therapeutic effects in eye conditions.
Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial DesignByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPHJuly 28th 2025
Parafoveal retinal vessel density assessment by OCTA in healthy eyesByMalvika Arya, BS,A. Yasin Alibhai, MD,Carl B. Rebhun, BA,Xuejing Chen, MD,Elias Reichel, MD ,Caroline R. Baumal, MD ,Andre J. Witkin, MD ,Jay S. Duker, MD ,Nadia K. Waheed, MD, MPHPublished: July 25th 2018 | Updated: April 25th 2024Study aims to identify methodology for least amount of variation, greatest test-retest reliability
